Advancing Pediatric Atopic Dermatitis Care: Challenges, Innovations, and Future Directions
This news content has been independently developed and is not endorsed by the American Academy of Dermatology:
Lisa Swanson, MD, FAAD; Aaron Farberg, MD; James Song, MD, FAAD; Alexandra Golant, MD, and Jennifer Soung, MD, discuss how, advancing pediatric atopic dermatitis management faces challenges of treatment adherence and limited pediatric-specific therapies. Recent innovations include targeted biologics, patient education tools, and multidisciplinary approaches. Future directions emphasize personalized medicine, barrier repair technologies, and improved quality-of-life assessment tools tailored to children's unique needs.
EP. 1: Challenges and Unmet Needs in Treating Pediatric Atopic Dermatitis
March 28th 2025Lisa Swanson, MD, FAAD, discusses how pediatric atopic dermatitis (AD) treatment challenges include limited approved options, safety concerns, and adherence issues. Effective management requires balancing new therapies like Janus kinase (JAK) inhibitors with safety while supporting caregivers through education.
EP. 4: Key Considerations for Evaluating Ruxolitinib Cream as a Treatment for Young Children
March 28th 2025Lisa Swanson, MD, FAAD, discusses how factors such as the safety profile, efficacy, age-appropriate dosing, and potential long-term effects of ruxolitinib cream would be crucial in determining its place in treatment for young children.
